JP Stock MarketDetailed Quotes
4875 MediciNova
- 241
- 00.00%
20min DelayMarket to Open Nov 7 15:30 JST
11.82BMarket Cap-10052P/E (Static)
0High0Low0Volume0Open241Pre Close0.00Turnover34452wk High0.00%Turnover Ratio49.05MShares15552wk Low-25.74EPS TTM10.14BFloat Cap1496Historical HighLossP/E (Static)42.09MShs Float129Historical Low-23.974EPS LYR0.00%Amplitude--Dividend TTM1.36P/B100Lot Size--Div YieldTTM
About MediciNova Company
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.
Company Profile
Symbol4875
Company NameMediciNova
Founded2000-09-26
Fiscal Year Ends12-31
Address4275 Executive Square Suite 300
Zip Code105-0003
Phone03-3519-5010
Company Executives
- Name
- Position
- Salary
- Dr. Yuichi Iwaki,M.D.,PhD
- Chairman of the Board, President and Chief Executive Officer
- 1.39M
- Dr. Kazuko Matsuda
- Director and Chief Medical Officer
- 1.01M
- David H. Crean, PhD
- Chief Business Officer
- --
- Jason J. Kruger
- Chief Financial Officer and Principal Accounting Officer
- --
- Nicole Lemerond
- Independent Director
- 46.16K
- Carolyn D. Beaver, C.P.A.
- Independent Director
- 69.23K
- Hideki Nagao
- Independent Director
- 69.23K
Analysis
Price Target
No Data
Heat List
JP
Overall
Symbol
Latest Price
% Chg
No Data